Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford surgeons have returned to the African children's hospital their colleague helped set up more than a decade ago. Staff from the Nuffield Orthopaedic Centre (NOC) teamed with counterparts in Malawi to run specialist training to tackle debilitating conditions such as club foot.

The week-long course was held at the Beit CURE International Hospital in the city of Blantyre, a facility that Nuffield Orthopaedic Surgeon Professor Chris Lavy helped to establish during his time working in the country in the early 2000s.

The training was part of the ongoing £1.4m COSECSA Oxford Orthopaedic Link (COOL) project to improve child healthcare across East, Central and Southern Africa that has seen medical specialists from Oxford University Hospitals NHS Trust help train more than 400 African counterparts in the past nine months. The next course will be held in Kenya in early 2014.

Read more (Nuffield Department of Orthopaedics, Rheumatology and Muscoloskeletal Sciences website) 

Read more (Oxford University Hospitals website) 

Similar stories

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.